주 메뉴 바로가기 본문 바로가기 하단 바로가기

A global leading company specializing in biosimilars' distribution

A biosimilar is a biologic product developed and proven to be biologically identical to a previously approved biologic known as the reference product using the same active substances. Known for its high quality and affordability, the biosimilar has become an innovative medicine for patients with different diseases across the world including Europe and the United States.

The first mAb biosimilar
in the world
Over the past few years, Celltrion Healthcare has been offering biosimilars for the treatment of autoimmune diseases in the global market and accumulating its marketing and distribution knowhow. Biosimilars have enabled patients from all over the world to benefit from a wide range of healthcare services and each country to reduce the fianancial burden associated with health care services.
Introducing new treatment options
by changing the method of delivery
A new method of delivery type can improve patient convenience and offer new treatment options to medical specialists. Celltrion Healthcare will play a crucial role in making this a reality, based on its global reach and extensive biopharmaceutical experience.

Cookie technology helps us bring you the best possible experience when you visit this website. If you continue without changing your settings, you are agreeing to the cookies on this website. To learn more about our policy on cookies, please review our privacy policy via the link at the bottom of the page.